Page 3 - Cosmetics Rules News Today

Patanjali Ayurved continues to faces rigorous scrutiny from the Supreme Court over misleading advertisements, with the case underscoring the vital need for strict regulatory oversight in health-related advertising in India.

"When you issue an apology, it does not mean that we have to see it by a microscope," Justice Kohli said.

The court admonished Patanjali for spreading misinformation that could undermine public trust in the health care system | Latest News India

The Supreme Court questioned the Central government over the failure to invoke the Drugs and Cosmetics Rules, 1945 against Patanjali Ayurved for broadcasting misleading advertisements

The Supreme Court questioned Patanjali Ayurved, co-founded by Baba Ramdev, about the size and expense of its apology published in newspapers

The apex court also took a dig at Patanjali Ayurveds public notice tendering unqualified public apology, asking if the size of the apology put out in 67 newspapers was similar to its full-page advertisements that it normally issued for its ayurvedic products. It asked Patanjali to bring on record within two days the “original” apology published in newspapers so as to check the size of the advertisement.

Expanding the scope of its hearing in the Patanjali Ayurved case, the Supreme Court on Tuesday took a stern view of misleading advertisements by Fast-Moving Consumer Goods (FMCG) firms and asked three Union ministries to inform it about the steps they have taken to curb the practice which takes public for a ride and adversely affects their health.

Patanjali assured the court that it would issue another, more prominently displayed apology in the media within a week. | Latest News India

A three-member committee of gynecologists has been formed to finalize a list of over-the-counter (OTC) drugs that will be available in regular stores without the need for a prescription. The committee, chaired by Directorate General of Health Services Atul Goel, aims to complete the list within two weeks. This move is part of Indias new OTC policy for drugs, which seeks to reduce treatment costs and promote self-care while ensuring safety. The list will be based on factors such as safety, availa...

Patanjali has been a repeat offender as far as misleading ads are concerned. Its promotion of Coronil during Covid and abuse of modern medicine doctors is what caught public attention and led to the Indian...